Cyclins and Cell Cycle Regulation

Pathway network for the Cyclins and Cell Cycle Regulation SuperPath

Sources:

QIAGEN

Pathways in the Cyclins and Cell Cycle Regulation SuperPath

#	Name	Source	Genes
1	Cyclins and Cell Cycle Regulation	QIAGEN	ATM ATR CCNA1 CCNA2 CCNB1 CCNB2 CCNB3 CCND1 CCND2 CCND3 CCNE1 CCNE2 CCNH CDC25A CDK1 CDK2 CDK4 CDK6 CDK7 CDKN1A CDKN1B CDKN2A CDKN2B CDKN2C CDKN2D E2F1 E2F2 E2F3 E2F4 E2F5 GSK3B HDAC1 HDAC10 HDAC11 HDAC2 HDAC3 HDAC5 HDAC6 HDAC7 HDAC8 HDAC9 LEFTY2 MYT1 PPP2CA PPP2CB PPP2R1A PPP2R1B PPP2R2A PPP2R2B PPP2R2C PPP2R3A PPP2R3B PPP2R5A PPP2R5B PPP2R5C PPP2R5E PTPA RAF1 RB1 TFDP1 TGFB1 TGFB2 TGFB3 TP53 WEE1 (see all 65) (see less)
2	G1-S Phase Transition	QIAGEN	ATM ATR CCNA1 CCNA2 CCND1 CCND2 CCND3 CCNE1 CCNE2 CDC25A CDK1 CDK2 CDK4 CDK6 CDKN1A CDKN1B CDKN2A CDKN2B CDKN2C CDKN2D E2F1 E2F2 E2F3 E2F4 E2F5 GSK3B HDAC1 HDAC10 HDAC11 HDAC2 HDAC3 HDAC5 HDAC6 HDAC7 HDAC8 HDAC9 LEFTY2 RB1 TFDP1 TGFB1 TGFB2 TGFB3 TP53 (see all 43) (see less)
3	Cell Cycle Control by BTG Proteins	QIAGEN	BTG1 BTG2 CCND1 CCNE1 CCNE2 CDK1 CDK2 CDK4 CNOT7 E2F1 E2F2 E2F3 E2F4 E2F5 HOXB9 NOCT PPP2CA PPP2CB PPP2R1A PPP2R1B PPP2R2A PPP2R2B PPP2R2C PPP2R3A PPP2R3B PPP2R5A PPP2R5B PPP2R5C PPP2R5E PRMT1 PTPA RB1 (see all 32) (see less)

Gene overlap in member pathways for Cyclins and Cell Cycle Regulation SuperPath

Ordered by rank within the SuperPath, via the multiplicity of each gene in the constituent pathways

#	Symbol	Description	Category	# Related Pathways
1	CCND1	Cyclin D1	Protein Coding	3
2	CCNE1	Cyclin E1	Protein Coding	3
3	CCNE2	Cyclin E2	Protein Coding	3
4	CDK1	Cyclin Dependent Kinase 1	Protein Coding	3
5	CDK2	Cyclin Dependent Kinase 2	Protein Coding	3
6	CDK4	Cyclin Dependent Kinase 4	Protein Coding	3
7	E2F1	E2F Transcription Factor 1	Protein Coding	3
8	E2F2	E2F Transcription Factor 2	Protein Coding	3
9	E2F3	E2F Transcription Factor 3	Protein Coding	3
10	E2F4	E2F Transcription Factor 4	Protein Coding	3
11	E2F5	E2F Transcription Factor 5	Protein Coding	3
12	RB1	RB Transcriptional Corepressor 1	Protein Coding	3
13	ATM	ATM Serine/Threonine Kinase	Protein Coding	2
14	ATR	ATR Checkpoint Kinase	Protein Coding	2
15	CCNA1	Cyclin A1	Protein Coding	2
16	CCNA2	Cyclin A2	Protein Coding	2
17	CCND2	Cyclin D2	Protein Coding	2
18	CCND3	Cyclin D3	Protein Coding	2
19	CDC25A	Cell Division Cycle 25A	Protein Coding	2
20	CDK6	Cyclin Dependent Kinase 6	Protein Coding	2
21	CDKN1A	Cyclin Dependent Kinase Inhibitor 1A	Protein Coding	2
22	CDKN1B	Cyclin Dependent Kinase Inhibitor 1B	Protein Coding	2
23	CDKN2A	Cyclin Dependent Kinase Inhibitor 2A	Protein Coding	2
24	CDKN2B	Cyclin Dependent Kinase Inhibitor 2B	Protein Coding	2
25	CDKN2C	Cyclin Dependent Kinase Inhibitor 2C	Protein Coding	2
26	CDKN2D	Cyclin Dependent Kinase Inhibitor 2D	Protein Coding	2
27	LEFTY2	Left-Right Determination Factor 2	Protein Coding	2
28	GSK3B	Glycogen Synthase Kinase 3 Beta	Protein Coding	2
29	HDAC1	Histone Deacetylase 1	Protein Coding	2
30	HDAC10	Histone Deacetylase 10	Protein Coding	2
31	HDAC11	Histone Deacetylase 11	Protein Coding	2
32	HDAC2	Histone Deacetylase 2	Protein Coding	2
33	HDAC3	Histone Deacetylase 3	Protein Coding	2
34	HDAC5	Histone Deacetylase 5	Protein Coding	2
35	HDAC6	Histone Deacetylase 6	Protein Coding	2
36	HDAC7	Histone Deacetylase 7	Protein Coding	2
37	HDAC8	Histone Deacetylase 8	Protein Coding	2
38	HDAC9	Histone Deacetylase 9	Protein Coding	2
39	PPP2CA	Protein Phosphatase 2 Catalytic Subunit Alpha	Protein Coding	2
40	PPP2CB	Protein Phosphatase 2 Catalytic Subunit Beta	Protein Coding	2
41	PPP2R1A	Protein Phosphatase 2 Scaffold Subunit Aalpha	Protein Coding	2
42	PPP2R1B	Protein Phosphatase 2 Scaffold Subunit Abeta	Protein Coding	2
43	PPP2R2A	Protein Phosphatase 2 Regulatory Subunit Balpha	Protein Coding	2
44	PPP2R2B	Protein Phosphatase 2 Regulatory Subunit Bbeta	Protein Coding	2
45	PPP2R2C	Protein Phosphatase 2 Regulatory Subunit Bgamma	Protein Coding	2
46	PPP2R3A	Protein Phosphatase 2 Regulatory Subunit B''''Alpha	Protein Coding	2
47	PTPA	Protein Phosphatase 2 Phosphatase Activator	Protein Coding	2
48	PPP2R5A	Protein Phosphatase 2 Regulatory Subunit B''Alpha	Protein Coding	2
49	PPP2R5B	Protein Phosphatase 2 Regulatory Subunit B''Beta	Protein Coding	2
50	PPP2R5C	Protein Phosphatase 2 Regulatory Subunit B''Gamma	Protein Coding	2
51	PPP2R5E	Protein Phosphatase 2 Regulatory Subunit B''Epsilon	Protein Coding	2
52	PPP2R3B	Protein Phosphatase 2 Regulatory Subunit B''''Beta~Name Same As:- HGNC:9310	Protein Coding	2
53	TFDP1	Transcription Factor Dp-1	Protein Coding	2
54	TGFB1	Transforming Growth Factor Beta 1	Protein Coding	2
55	TGFB2	Transforming Growth Factor Beta 2	Protein Coding	2
56	TGFB3	Transforming Growth Factor Beta 3	Protein Coding	2
57	TP53	Tumor Protein P53	Protein Coding	2
58	CCNB1	Cyclin B1	Protein Coding	1
59	CCNB2	Cyclin B2	Protein Coding	1
60	CCNB3	Cyclin B3	Protein Coding	1
61	CCNH	Cyclin H	Protein Coding	1
62	CDK7	Cyclin Dependent Kinase 7	Protein Coding	1
63	MYT1	Myelin Transcription Factor 1	Protein Coding	1
64	RAF1	Raf-1 Proto-Oncogene, Serine/Threonine Kinase	Protein Coding	1
65	WEE1	WEE1 G2 Checkpoint Kinase	Protein Coding	1
66	BTG1	BTG Anti-Proliferation Factor 1	Protein Coding	1
67	BTG2	BTG Anti-Proliferation Factor 2	Protein Coding	1
68	NOCT	Nocturnin	Protein Coding	1
69	CNOT7	CCR4-NOT Transcription Complex Subunit 7	Protein Coding	1
70	HOXB9	Homeobox B9	Protein Coding	1
71	PRMT1	Protein Arginine Methyltransferase 1	Protein Coding	1

Disorders associated with Cyclins and Cell Cycle Regulation SuperPath

according to GeneCards Suite gene sharing

#	Disorder	Type	Genes	Score
1	Multiple endocrine neoplasia, type i	Enrichment	CDKN1A, CDKN1B, CDKN2B, CDKN2C	8.51
2	Bladder cancer	Enrichment	ATM, CDKN1A, CDKN2A, RB1, TP53	7.55
3	Inherited cancer-predisposing syndrome	Enrichment	ATM, CDK4, CDKN1B, CDKN2A, RB1, TP53	5.46
4	Leukemia, chronic lymphocytic	Enrichment	ATM, CCND1, TP53	5.46
5	Lip and oral cavity carcinoma	Enrichment	CDKN2A, RB1, TP53	5.19
6	Loeys-dietz syndrome 4	Enrichment	TGFB2, TGFB3	5.01
7	Gastric cancer	Enrichment	ATM, CDK4, CDKN2A, TP53	5.01
8	Ovarian cancer	Enrichment	ATM, CDKN1B, CDKN2A, RB1, TP53	4.80
9	Melanoma, cutaneous malignant 1	Enrichment	CDK4, CDKN2A, CDKN2B	4.71
10	Myeloma, multiple	Enrichment	ATM, CCND1, CDKN2C, TP53	4.54
11	Osteogenic sarcoma	Enrichment	RB1, TP53	4.53
12	Squamous cell carcinoma	Enrichment	RB1, TP53	4.53
13	Adenocarcinoma	Enrichment	ATM, TP53	4.53
14	Bone osteosarcoma	Enrichment	RB1, TP53	4.53
15	Small cell cancer of the lung	Enrichment	RB1, TP53	4.23
16	Mantle cell lymphoma	Enrichment	ATM, CCND1	4.23
17	Pancreatic cancer	Enrichment	ATM, CDKN2A, TP53	4.19
18	Li-fraumeni syndrome	Enrichment	CDKN2A, TP53	3.84
19	Adrenocortical carcinoma	Enrichment	CDKN2A, TP53	3.84
20	B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)	Enrichment	CDKN2A, TP53	3.69
21	Loeys-dietz syndrome	Enrichment	TGFB2, TGFB3	3.46
22	Lung cancer susceptibility 3	Enrichment	RB1, TP53	3.06
23	Gliosarcoma	Enrichment	ATM, TP53	2.94
24	Giant cell glioblastoma	Enrichment	ATM, TP53	2.89
25	Breast cancer	Enrichment	ATM, CDKN2B, TP53	2.77
26	Melanoma, cutaneous malignant 3	Enrichment	CDK4	2.63
27	Spinocerebellar ataxia 12	Enrichment	PPP2R2B	2.63
28	Parkinson disease 25, autosomal recessive early-onset, with impaired intellectual development	Enrichment	PTPA	2.63
29	Houge-janssens syndrome 4	Enrichment	PPP2R5C	2.63
30	Houge-janssens syndrome 2	Enrichment	PPP2R1A	2.63
31	Trilateral retinoblastoma	Enrichment	RB1	2.63
32	Ppp2r1a-related neurodevelopmental disorder	Enrichment	PPP2R1A	2.63
33	Lung oat cell carcinoma	Enrichment	RB1	2.63
34	Colorectal cancer	Enrichment	ATM, CCND1, TP53	2.58
35	Chondrodysplasia with platyspondyly, distinctive brachydactyly, hydrocephaly, and microphthalmia	Enrichment	HDAC6	2.50
36	Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 3	Enrichment	CCND2	2.50
37	Seckel syndrome 1	Enrichment	ATR	2.50
38	Microcephaly 12, primary, autosomal recessive	Enrichment	CDK6	2.50
39	Auriculocondylar syndrome 4	Enrichment	HDAC9	2.50
40	Cornelia de lange syndrome 5	Enrichment	HDAC8	2.50
41	Bone marrow failure syndrome 5	Enrichment	TP53	2.50
42	Papilloma of choroid plexus	Enrichment	TP53	2.50
43	Basal cell carcinoma 7	Enrichment	TP53	2.50
44	Anaplastic thyroid carcinoma	Enrichment	TP53	2.50
45	Camurati-engelmann disease 2	Enrichment	TGFB2	2.50
46	Neuroendocrine tumor	Enrichment	CDKN1B	2.50
47	Cutaneous telangiectasia and cancer syndrome, familial	Enrichment	ATR	2.50
48	Endometrial serous adenocarcinoma	Enrichment	ATM	2.50
49	Ductal carcinoma in situ	Enrichment	TP53	2.50
50	Loeys-dietz syndrome 5	Enrichment	TGFB3	2.50
51	Thyroid gland undifferentiated carcinoma	Enrichment	TP53	2.50
52	Small-cell carcinoma of the ovary of hypercalcemic type	Enrichment	TP53	2.50
53	Cdkn2a cancer predisposition	Enrichment	CDKN2A	2.50
54	Diffuse pediatric-type high-grade glioma, h3-wildtype and idh-wildtype	Enrichment	TP53	2.50
55	B-cell non-hodgkin lymphoma	Enrichment	ATM	2.50
56	Choroid plexus cancer	Enrichment	TP53	2.50
57	Pleomorphic xanthoastrocytoma	Enrichment	TP53	2.50
58	Familial cutaneous telangiectasia and oropharyngeal predisposition cancer syndrome	Enrichment	ATR	2.50
59	Prostate cancer	Enrichment	ATM, TP53	2.42
60	Chromosome 13q14 deletion syndrome	Enrichment	RB1	2.33
61	Houge-janssens syndrome 3	Enrichment	PPP2CA	2.33
62	Familial retinoblastoma	Enrichment	RB1	2.33
63	Noonan syndrome 5	Enrichment	RAF1	2.32
64	Cardiomyopathy, dilated, 1nn	Enrichment	RAF1	2.32
65	Leopard syndrome 2	Enrichment	RAF1	2.32
66	Trigonitis	Enrichment	RAF1	2.32
67	Melanoma-astrocytoma syndrome	Enrichment	CDKN2A	2.20
68	Adrenocortical carcinoma, hereditary	Enrichment	TP53	2.20
69	Camurati-engelmann disease 1	Enrichment	TGFB1	2.20
70	Cervical cancer	Enrichment	TP53	2.20
71	Melanoma, cutaneous malignant 2	Enrichment	CDKN2A	2.20
72	Lymphoma, hodgkin, classic	Enrichment	TP53	2.20
73	Syndactyly, type iii	Enrichment	HDAC8	2.20
74	Multiple endocrine neoplasia, type iv	Enrichment	CDKN1B	2.20
75	Cardiac valvular dysplasia, x-linked	Enrichment	ATM	2.20
76	Inflammatory bowel disease, immunodeficiency, and encephalopathy	Enrichment	TGFB1	2.20
77	Wilson-turner syndrome	Enrichment	HDAC8	2.20
78	Melanoma-pancreatic cancer syndrome	Enrichment	CDKN2A	2.20
79	Camurati-engelmann disease	Enrichment	TGFB1	2.20
80	Congenital fibrosarcoma	Enrichment	TP53	2.20
81	High grade glioma	Enrichment	ATM	2.20
82	Li-fraumeni syndrome 1	Enrichment	TP53	2.20
83	Sarcoma	Enrichment	TP53	2.20
84	Cervix carcinoma	Enrichment	TP53	2.20
85	Hodgkin's lymphoma	Enrichment	TP53	2.20
86	T-cell prolymphocytic leukemia	Enrichment	ATM	2.20
87	Pleomorphic rhabdomyosarcoma	Enrichment	TP53	2.20
88	Retinoblastoma	Enrichment	RB1	2.15
89	Woolly hair, autosomal recessive 3	Enrichment	RB1	2.15
90	Hypotrichosis 8	Enrichment	RB1	2.15
91	Dedifferentiated liposarcoma	Enrichment	CDK4	2.15
92	Well-differentiated liposarcoma	Enrichment	CDK4	2.15
93	Familial thoracic aortic aneurysm and aortic dissection	Enrichment	TGFB2, TGFB3	2.07
94	Hereditary breast carcinoma	Enrichment	ATM, TP53	2.07
95	Lynch syndrome 4	Enrichment	RB1	2.03
96	Ataxia-telangiectasia	Enrichment	ATM	2.02
97	Polycythemia vera	Enrichment	ATM	2.02
98	Nasopharyngeal carcinoma	Enrichment	TP53	2.02
99	Koolen-de vries syndrome	Enrichment	ATM	2.02
100	Atypical teratoid rhabdoid tumor	Enrichment	TP53	2.02
101	Anaplastic astrocytoma	Enrichment	TP53	2.02
102	Von hippel-lindau syndrome	Enrichment	CCND1	1.93
103	Thyroid cancer, nonmedullary, 1	Enrichment	TP53	1.90
104	Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1	Enrichment	CCND2	1.90
105	Lung sarcomatoid carcinoma	Enrichment	TP53	1.90
106	Embryonal rhabdomyosarcoma	Enrichment	TP53	1.90
107	Primary hyperparathyroidism	Enrichment	CDKN1B	1.90
108	Oculomotor apraxia	Enrichment	ATM	1.90
109	Hereditary breast ovarian cancer syndrome	Enrichment	ATM, TP53	1.88
110	Wieacker-wolff syndrome	Enrichment	CCNH	1.84
111	Arrhythmogenic right ventricular dysplasia, familial, 1	Enrichment	TGFB3	1.80
112	Rhabdomyosarcoma 2	Enrichment	TP53	1.80
113	Lymphoma	Enrichment	TP53	1.80
114	Glioblastoma	Enrichment	ATM	1.80
115	Arrhythmogenic right ventricular dysplasia 1	Enrichment	TGFB3	1.80
116	Acute megakaryocytic leukemia	Enrichment	TP53	1.80
117	Atrial septal defect 1	Enrichment	TGFB2	1.72
118	Inflammatory bowel disease 25, autosomal recessive	Enrichment	TGFB1	1.72
119	Clear cell renal cell carcinoma	Enrichment	ATM	1.72
120	Il10-related early-onset inflammatory bowel disease	Enrichment	TGFB1	1.72
121	Breast adenocarcinoma	Enrichment	TP53	1.72
122	Lung squamous cell carcinoma	Enrichment	CDKN2A	1.72
123	Noonan syndrome with multiple lentigines	Enrichment	RAF1	1.72
124	Pregnancy loss, recurrent 1	Enrichment	CCNB3	1.72
125	Esophageal cancer	Enrichment	TP53	1.66
126	Squamous cell carcinoma, head and neck	Enrichment	TP53	1.66
127	Renal cell carcinoma, papillary, 1	Enrichment	ATM	1.66
128	Essential thrombocythemia	Enrichment	TP53	1.66
129	Gallbladder cancer	Enrichment	TP53	1.66
130	Capillary malformations, congenital	Enrichment	CCNH	1.62
131	Glioma susceptibility 1	Enrichment	TP53	1.60
132	Fanconi anemia, complementation group c	Enrichment	HDAC8	1.60
133	Lymphoma, non-hodgkin, familial	Enrichment	TP53	1.60
134	Cornelia de lange syndrome 1	Enrichment	HDAC8	1.55
135	Adult hepatocellular carcinoma	Enrichment	TP53	1.55
136	Primary hyperaldosteronism	Enrichment	TP53	1.55
137	Colonic benign neoplasm	Enrichment	ATM	1.55
138	Cornelia de lange syndrome	Enrichment	HDAC8	1.55
139	Klippel-trenaunay-weber syndrome	Enrichment	CCNH	1.55
140	Telangiectasia, hereditary hemorrhagic, type 1	Enrichment	CCNH	1.55
141	Hemangioma, capillary infantile	Enrichment	CCNH	1.55
142	Basal cell carcinoma 1	Enrichment	CCNH	1.55
143	Lynch syndrome 1	Enrichment	ATM	1.50
144	Marfan syndrome	Enrichment	TGFB2	1.50
145	Melanoma	Enrichment	CDKN2A	1.50
146	Familial colorectal cancer	Enrichment	TP53	1.50
147	Capillary malformation-arteriovenous malformation 1	Enrichment	CCNH	1.48
148	Noonan syndrome 3	Enrichment	RAF1	1.48
149	Hereditary hemorrhagic telangiectasia	Enrichment	CCNH	1.48
150	Pilomyxoid astrocytoma	Enrichment	RAF1	1.48
151	Immune deficiency disease	Enrichment	ATM	1.46
152	Leukemia, acute lymphoblastic	Enrichment	CDKN2A	1.46
153	Myelodysplastic syndrome	Enrichment	TP53	1.46
154	Atrial heart septal defect	Enrichment	HDAC8	1.46
155	Uterine corpus cancer	Enrichment	ATM	1.46
156	Interatrial communication	Enrichment	HDAC8	1.46
157	Familial colorectal cancer type x	Enrichment	ATM	1.46
158	Inherited isolated arrhythmogenic ventricular dysplasia, biventricular variant	Enrichment	TGFB3	1.43
159	Inherited isolated arrhythmogenic cardiomyopathy, dominant-left variant	Enrichment	TGFB3	1.43
160	Melanocytic nevus syndrome, congenital	Enrichment	RAF1	1.42
161	Breast-ovarian cancer, familial 1	Enrichment	ATM	1.39
162	Arteriovenous malformation	Enrichment	CCNH	1.37
163	Seckel syndrome	Enrichment	ATR	1.36
164	Inherited isolated arrhythmogenic cardiomyopathy, dominant-right variant	Enrichment	TGFB3	1.36
165	Renal cell carcinoma, nonpapillary	Enrichment	ATM	1.33
166	Myopathy, x-linked, with excessive autophagy	Enrichment	CCNH	1.33
167	Rhabdomyosarcoma	Enrichment	TP53	1.30
168	Polycystic liver disease	Enrichment	CDC25A	1.28
169	Autosomal dominant polycystic liver disease	Enrichment	CDC25A	1.28
170	Polycystic kidney disease	Enrichment	HDAC8	1.26
171	Diffuse large b-cell lymphoma	Enrichment	TP53	1.23
172	Ehlers-danlos syndrome	Enrichment	TGFB2	1.23
173	Endometrial cancer	Enrichment	ATM	1.19
174	Hepatoblastoma	Enrichment	TP53	1.19
175	Hepatocellular carcinoma	Enrichment	TP53	1.17
176	Visceral heterotaxy	Enrichment	LEFTY2	1.17
177	Noonan syndrome and noonan-related syndrome	Enrichment	RAF1	1.16
178	Diamond-blackfan anemia 1	Enrichment	TP53	1.15
179	Precursor t-cell acute lymphoblastic leukemia	Enrichment	CDKN2A	1.15
180	Lung cancer	Enrichment	PPP2R1B	1.14
181	Cystic fibrosis	Enrichment	TGFB1	1.01
182	Primary autosomal recessive microcephaly	Enrichment	CDK6	1.01
183	Noonan syndrome 1	Enrichment	RAF1	0.98
184	Diamond-blackfan anemia	Enrichment	TP53	0.97
185	Cardiomyopathy, familial hypertrophic, 1	Enrichment	RAF1	0.96
186	Rasopathy	Enrichment	RAF1	0.93
187	Leukemia, acute myeloid	Enrichment	TP53	0.92
188	Familial hypertrophic cardiomyopathy	Enrichment	RAF1	0.83
189	Left ventricular noncompaction	Enrichment	RAF1	0.81
190	Familial isolated dilated cardiomyopathy	Enrichment	RAF1	0.65
191	Complex neurodevelopmental disorder	Enrichment	PPP2CA	0.59
192	Dilated cardiomyopathy	Enrichment	RAF1	0.50
193	Microcephaly	Enrichment	HDAC8	0.49

¹ WikiPathways

² PubChem

³ R&D Systems

⁴ Reactome

⁵ GeneGo (Thomson Reuters)

⁶ QIAGEN

⁷ PharmGKB

⁸ Cell Signaling Technology

⁹ Sino Biological

¹⁰ Tocris

¹¹ MalaCards

Cyclins and Cell Cycle Regulation

Pathway Network for Cyclins and Cell Cycle Regulation

Pathway network for the Cyclins and Cell Cycle Regulation SuperPath

Member Pathways for Cyclins and Cell Cycle Regulation

Pathways in the Cyclins and Cell Cycle Regulation SuperPath

Gene overlap in member pathways for Cyclins and Cell Cycle Regulation SuperPath

Associated Genes for Cyclins and Cell Cycle Regulation

Associated Disorders for Cyclins and Cell Cycle Regulation

Disorders associated with Cyclins and Cell Cycle Regulation SuperPath

STRING Interaction Network for Cyclins and Cell Cycle Regulation

Sources for Cyclins and Cell Cycle Regulation